Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SANUWAVE Health (SNWV) Other financing activities (2019 - 2020)

SANUWAVE Health (SNWV) reported Other financing activities of $16000.0 for Q2 2020, down 91.11% year-over-year from $180000.0 in Q3 2019, and up 662.63% on a QoQ basis from $2098.0 in Q1 2020.

SANUWAVE Health (SNWV) has 2 years of Other financing activities data on file, last reported at $16000.0 in Q2 2020.

  • Quarterly Other financing activities fell 91.11% year-over-year to $16000.0 in Q2 2020, while the trailing twelve-month figure through Dec 2025 was $16000.0 (down 11.59% YoY) and the FY2025 annual result came in at $371000.0, changed N/A from the prior year.
  • Other financing activities advanced to $16000.0 in Q2 2020 per SNWV's latest filing, from $2098.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $180000.0 in Q2 2019 and bottomed at -$180000.0 in Q3 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 SANUWAVE Health 137.37 Mn 126.59 Mn 7.43 Mn

Historic Data

Download Data 🔒
DateValue
Jun 30, 2020 16,000.00
Jun 30, 2020 16,000.00
Mar 31, 2020 2,098.00
Mar 31, 2020 2,098.00
Sep 30, 2019 -180,000.00
Sep 30, 2019 -180,000.00
Jun 30, 2019 180,000.00
Jun 30, 2019 180,000.00